Sharekhan

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

What’s Your Call?

Collective community sentiment on Trident Lifeline Ltd

Your Vote -

Buy

25.00%

Hold

50.00%

Sell

25.00%

25.00%

4 users have voted

No Records Found

Option Chain

Analyzes market sentiment, predicts Trident Lifeline Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Trident Lifeline - Intimation Pursuant To Regulation 30 - Corporate Guarantee

    12 Mar 2025, 5:33PM Trident Lifeline Limited has provided Corporate Guarantee in favor of Yes Bank
  • Trident Lifeline - Announcement under Regulation 30 (LODR)-Memorandum of Understanding /Agreements

    5 Mar 2025, 7:05PM Trident Lifeline Limited is pleased to inform you about the strategic alliance with National Institutes of Pharmaceutical Education and Research- Ahme
  • Trident Lifeline - Disclosure As Per Regulation 7(2) Of SEBI (Prohibition Of Insider Trading) Regulations, 2015

    5 Mar 2025, 6:58PM Pursuant to Regulation 7(2) of SEBI (Prohibition of Insider Trading) Regulations, 2015 (PIT Regulations), we are enclosing herewith the disclosures re
  • Trident Lifeline - Disclosure Under Regulation 29(1) Of SEBI (Substantial Acquisition Of Shares And Takeover) Regulations, 20

    5 Mar 2025, 6:56PM In compliance with Regulation 29 of SEBI (Substantial Acquisition of Shares and Takeover) Regulations, 2011, please find enclosed herewith disclosure
  • Trident Lifeline - Disclosure As Per Regulation 7(2) Of SEBI (Prohibition Of Insider Trading) Regulations, 2015

    5 Mar 2025, 6:54PM Pursuant to Regulation 7(2) of SEBI (Prohibition of Insider Trading) Regulations, 2015 (PIT Regulations), we are enclosing herewith the disclosures re
  • Trident Lifeline - Disclosure Under Regulation 29(2) Of SEBI (Substantial Acquisition Of Shares And Takeover) Regulations, 20

    5 Mar 2025, 6:52PM In compliance with Regulation 29 of SEBI (Substantial Acquisition of Shares and Takeover) Regulations, 2011, please find enclosed herewith disclosure
  • Trident Lifeline - Intimation Pursuant To Regulation 30 - Corporate Guarantee

    25 Feb 2025, 6:42PM Trident Lifeline Limited has provided Corporate Guarantee in favor of Yes Bank on behalf of its Subsidiary Company.
  • Trident Lifeline - Intimation Pursuant To Regulation 30 - Corporate Guarantee

    14 Feb 2025, 7:17PM Trident Lifeline Limited has provided Corporate Guarantee to Subsidiary of the Company.
  • Trident Lifeline - Announcement under Regulation 30 (LODR)-Updates on Acquisition

    4 Feb 2025, 4:00PM With reference to our intimation dated December 23, 2024 and January 22, 2025 we wish to inform to the Exchange that the said transaction as mentioned
  • Trident Lifeline Q3 net profit zooms 103.36% at Rs 3.03 cr

    22 Jan 2025, 6:20PM The company reported standalone net profit of Rs 3.03 crore for the quarter ended December 31, 2024 as compared to Rs 1.49 crore in the same period la
  • Trident Lifeline - Integrated Filing (Financial)

    22 Jan 2025, 6:12PM Company has submitted integrated filing (Financial) for Quarter and nine months ended December 31, 2024.
  • Trident Lifeline - Announcement under Regulation 30 (LODR)-Updates on Acquisition

    22 Jan 2025, 5:58PM Update on acquisition of Trident Mediquip Limited
  • Trident Lifeline - Statement Of Deviation Or Variation Of Funds Under Regulation 32 Of SEBI (Listing Obligations And Disclosu

    22 Jan 2025, 5:51PM Please find attached herewith Statement Of Deviation Or Variation Of Funds Under Regulation 32 Of SEBI (Listing Obligations And Disclosure Requirement
  • Trident Lifeline - Result-Financial Result For The Quarter And Nine Months Ended December 31, 2024

    22 Jan 2025, 5:42PM Trident Lifeline Limited has submitted the financial result for the Quarter and Nine months ended on December 31, 2024.
  • Trident Lifeline - Board Meeting Outcome for Board Meeting Outcome For Financial Results For The Quarter And Nine Months Ende

    22 Jan 2025, 5:37PM Trident Lifeline Limited has submitted to Exchange the outcome of Board Meeting held on 22.01.2024
  • Trident Lifeline - Board Meeting Intimation for Consider And Approve The Unaudited Financial Results For Quarter Ended 31St D

    16 Jan 2025, 7:25PM Trident Lifeline Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/01/2025 ,inter alia, to consider and
  • Trident Lifeline - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    4 Jan 2025, 6:45PM Please find enclosed herewith the Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 as received from MUFG I
  • Trident Lifeline - Intimation Of Change Of Name Of Registrar And Share Transfer Agent Of The Company.

    2 Jan 2025, 1:52PM Intimation of Change of name of Registrar and Share Transfer Agent ('RTA') of the Company from Link Intime India Private Limited to MUFG Intime India
  • Trident Lifeline - Announcement under Regulation 30 (LODR)-Acquisition

    24 Dec 2024, 5:13PM Correction in the intimation letter dated December 23, 2024
  • Trident Lifeline - Announcement under Regulation 30 (LODR)-Acquisition

    23 Dec 2024, 8:14PM The Company has proposed to acquire 51% of the Equity Share Capital of TRIDENT MEDIQUIP LIMITED (CIN: U33309GJ2019PLC110421). Further details as per S
  • Trident Lifeline - Outcome Of Board Meeting

    23 Dec 2024, 8:12PM \r\nThe Company has proposed to acquire 51% of the Equity Share Capital of TRIDENT MEDIQUIP LIMITED (CIN: U33309GJ2019PLC110421). Further details as p
  • Trident Lifeline - Board Meeting Outcome for Outcome Of Board Meeting Held On December 23, 2024

    23 Dec 2024, 8:10PM The Company has proposed to acquire 51% of the Equity Share Capital of TRIDENT MEDIQUIP LIMITED (CIN: U33309GJ2019PLC110421).
  • Trident Lifeline - Revised Unaudited Financial Results For The Half Year Ended September 30, 2024.

    20 Dec 2024, 2:05PM Rectification with respect to the bifurcation of Trade Payable in financial results as per accounting standard is made being intimated by BSE via emai

Key fundamentals

Evaluate the intrinsic value of Trident Lifeline Ltd stock 

Name March-24 March-23 March-22 March-21
Assets 58.8707 49.0094 7.2556 4.0546
Liabilities 58.8707 49.0094 7.2556 4.0546
Equity 11.4992 11.4992 8 5
Gross Profit 8.8297 6.2509 2.7613 1.2432
Net Profit 7.0434 6.012 2.2732 0.6323
Cash From Operating Activities 0.8953 -16.6037 -0.2521 1.4846
NPM(%) 15.77 18.96 10.44 6.57
Revenue 44.6524 31.6922 21.7679 9.6223
Expenses 35.8227 25.4413 19.0066 8.3791
ROE(%) 12.23 10.44 3.94 1.09

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to Trident Lifeline Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 809.25 -0.64 11.41 142.39 1321.50 1.42
Lotus Eye Hospital and Institute Ltd 58.19 1.50 237.75 518.87 14.01 0.88
Bharat Immunological and Biologicals Corporation Ltd 21.32 -1.30 0.00 1077.34 -39.50 0.00
Astec Lifesciences Ltd 654.90 -5.39 0.00 489.25 -239.30 0.00

Company Info

Our Company was originally incorporated as "Trident Lifeline Private Limited" as a Private Limited Company under the provisions of the Companies Act, 1956 vide Certificate of Incorporation dated January 09, 2014, issued by the Registrar of Companies, Gujarat, Dadra and Nagar Havelli. Subsequently, our Company was converted into a Public Limited Company pursuant to shareholders resolution passed at Extra-ordinary General Meeting of our Company held on June 02, 2022 and the name of our Company was changed to "Trident Lifeline Limited". A fresh Certificate of Incorporation consequent upon Conversion from Private Limited Company to Public Limited Company dated June 10, 2022 was issued by the Registrar of Companies, Ahmedabad. The Corporate Identification Number of our Company is U51909GJ2014PLC078227.Our promoters and directors have a combined experience of more than 19 years in the pharmaceutical products, Bulk drugs. Driven by the passion for building an integrated pharmaceutical company, backed by their experience, our Promoters have been the pillars of our Company's growth and have built a strong value system for our Company. With their enriching experience and progressive thinking, we aim to continue to grow in the pharmaceutical and bulk drugs industry.Our Company is engaged in the pharmaceutical business ethical marketing in domestic as well as inernational market. We are also engaged in distribution of pharmaceutical products through third party distribution network. We offer wide range of pharmaceutical formulations and products manufactured on contract manufacturing under loan lisence. We operate in India as well as African, Latin American and East Indian Countries. We have our presence through registered products or products under registration in countries like Bolivia, Cambodia, Cameroon, Chile, Ghana, Kenya, Myanamar, Nigeria, Peru, Sudan, Tajikistan, Uzbekistan, Venuzela.We deal in Capsules, Tablets, Liquid Ointment, Gel, Ice Gel, Mouthwash, Paste, Solution, Suspension, Drypowders and Toothpaste. Our product portfolio comprises of vide range of drugs like Anti Bacterial, Anti Diarrheal, Anti Fungal, Anti Malerial, Anti Diabetic, Dental Cure, Proton Pump Inhibitor, Anti Protozol, Anti Histamine, Anti Hypertensive drugs, Anti Lipidemic Drug, Anti Parasitic, Multivitamin, Multimineral Nyteraceutical and Non-steriodal anti-inflamatory drug (NSAIDS). Our product portfolio consists of 832 products, as on May 31, 2022. We operate under different brand names across the globe. As on May 31, 2022, we have 267 products registered in total 8 countries. As on May 31, 2022, total565 products are under process of registration in 11 countries, which shall boost the growth of our company.MAJOR EVENTS2014Our Company was incorporated as a private limited company under the name "Trident Lifeline Private Limited" Limited2021Our Company had Certified its Quality Management System Under the Certificate ISO 9001:2015. 2021 -Exports to LATAM and CIS Countries. 2022 -Acquisition of TNS Pharma Pvt. Ltd. 2024 -Acquisition of TLL Herbal Ltd. -Acquisition of 18% equity in Tricorp

Our Company was originally incorporated as "Trident Lifeline Private Limited" as a Private Limited Company under the provisions of the Companies Act, 1956 vide Certificate of Incorporation dated January 09, 2014, issued by the Registrar of Companies, Gujarat, Dadra and Nagar Havelli. Subsequently, our Company was converted into a Public Limited Company pursuant to shareholders resolution passed at Extra-ordinary General Meeting of our Company held on June 02, 2022 and the name of our Company was changed to "Trident Lifeline Limited". A fresh Certificate of Incorporation consequent upon Conversion from Private Limited Company to Public Limited Company dated June 10, 2022 was issued by the Registrar of Companies, Ahmedabad. The Corporate Identification Number of our Company is U51909GJ2014PLC078227.Our promoters and directors have a combined experience of more than 19 years in the pharmaceutical products, Bulk drugs. Driven by the passion for building an integrated pharmaceutical company, backed by their experience, our Promoters have been the pillars of our Company's growth and have built a strong value system for our Company. With their enriching experience and progressive thinking, we aim to continue to grow in the pharmaceutical and bulk drugs industry.Our Company is engaged in the pharmaceutical business ethical marketing in domestic as well as inernational market. We are also engaged in distribution of pharmaceutical products through third party distribution network. We offer wide range of pharmaceutical formulations and products manufactured on contract manufacturing under loan lisence. We operate in India as well as African, Latin American and East Indian Countries. We have our presence through registered products or products under registration in countries like Bolivia, Cambodia, Cameroon, Chile, Ghana, Kenya, Myanamar, Nigeria, Peru, Sudan, Tajikistan, Uzbekistan, Venuzela.We deal in Capsules, Tablets, Liquid Ointment, Gel, Ice Gel, Mouthwash, Paste, Solution, Suspension, Drypowders and Toothpaste. Our product portfolio comprises of vide range of drugs like Anti Bacterial, Anti Diarrheal, Anti Fungal, Anti Malerial, Anti Diabetic, Dental Cure, Proton Pump Inhibitor, Anti Protozol, Anti Histamine, Anti Hypertensive drugs, Anti Lipidemic Drug, Anti Parasitic, Multivitamin, Multimineral Nyteraceutical and Non-steriodal anti-inflamatory drug (NSAIDS). Our product portfolio consists of 832 products, as on May 31, 2022. We operate under different brand names across the globe. As on May 31, 2022, we have 267 products registered in total 8 countries. As on May 31, 2022, total565 products are under process of registration in 11 countries, which shall boost the growth of our company.MAJOR EVENTS2014Our Company was incorporated as a private limited company under the name "Trident Lifeline Private Limited" Limited2021Our Company had Certified its Quality Management System Under the Certificate ISO 9001:2015. 2021 -Exports to LATAM and CIS Countries. 2022 -Acquisition of TNS Pharma Pvt. Ltd. 2024 -Acquisition of TLL Herbal Ltd. -Acquisition of 18% equity in Tricorp

Read More

Parent Organisation

Trident Lifeline Ltd.

Founded

09/01/2014

Managing Director

Mr.Shravan Harikrishna Patel

NSE Symbol

FAQ

The current price of Trident Lifeline Ltd is

The 52-week high for Trident Lifeline Ltd is

The market capitalization of Trident Lifeline Ltd is currently This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Trident Lifeline Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Trident Lifeline Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Trident Lifeline Ltd shares.

The CEO of Trident Lifeline Ltd is Mr.Shravan Harikrishna Patel, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT